Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Pharmaceutical Glass Packaging Market Report 2021: Joint Ventures / M&A / New Product Launches & Capacity Expansion

DUBLIN, Sept. 24, 2021 /PRNewswire/ -- The "Global Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report by Product (Vials, Bottles, Cartridges & Syringes, Ampoules), by Drug Type (Generic, Branded, Biologic), by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global pharmaceutical glass packaging market size is expected to reach USD 7.46 billion by 2028. It is expected to expand at a CAGR of 8.8% from 2021 to 2028.

The demand for pharmaceutical glass packaging is projected to be driven by the growth of the pharmaceutical industry in emerging economies, especially in the Asia Pacific region.

The cost sensitivity in the healthcare sector and the growing significance of biotech drugs have resulted in the establishment of stringent regulations related to drug delivery products. Many pharmaceutical drugs manufacturing companies are focused on increasing the shelf life of a drug and are therefore making investments in the research and development of glass vials. The newly developed products are expected to aid the growth of glass vials due to the expansive number of applications.

The generic drug type segment is expected to witness the fastest growth in terms of revenue as well as volume over the forecast period. This is due to the significant increase in the volume of generics in the country, which is estimated to face a rapid change in the market dynamics primarily due to the increased competitive intensity and customer consolidation.

Glass packaging is highly preferred in the pharmaceutical industry as it is easy to sterilize with heat and does not react with most of the drugs and medicines being chemically inert. The colored glass packaging can protect the medicines from different wavelengths, including UV rays of the sun. Additionally, glass is easily available all over the world and can be recycled, which has made it an ideal material for the packaging of pharmaceutical products.

The market in North America is expected to witness steady growth in the years to come on account of global key players present in the region. With the rising volume of generic drugs, glass packaging has been increasingly adopted owing to the preexisting established supply chain. The recent outbreak of COVID-19 has positively impacted the market growth due to the growing use of pharmaceutical glass packaging in the packaging of immunity-boosting drugs.

Companies in the pharmaceutical glass packaging industry have been trying to improve product strength to reduce breakage during the filling of vials. In September 2019, Corning Inc. got approval from the FDA to market its Corning Valor Glass, which enables superior chemical durability and improves resistance to breakage, damage, and particulate contamination.

For instance, Gerresheimer AG, a key German-based pharma glass packaging manufacturer, has developed a metal-free 1 ml Gx RTF long Luer Lock syringe. This particular syringe uses a new technology in which the pin used to shape the cone is made of a special ceramic material instead of the conventional tungsten or alternative metal.

Pharmaceutical Glass Packaging Market Report Highlights

Pharmaceutical Glass Packaging Market Variables, Trends & Scope

Market Lineage Outlook

Penetration & Growth Prospect Mapping

Value Chain Analysis

Regulatory Framework

Market Driver Analysis

Market Restraints Analysis

Major Deals & Strategic Alliances Analysis

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/rdexhd

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

These press releases may also interest you

at 09:31
On October 27, Inner Mongolia Yili Industrial Group Co., Ltd. ("Yili Group" or "Yili"), the largest dairy producer in Asia, announced that it took a stake in goat milk formula giant Ausnutria Dairy Co. Ltd. ("Ausnutria Dairy" or "Ausnutria") and...

at 09:30
The "Global Pharmacovigilance Market, By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), By Method, By Service Provider, By Process Flow, By Therapeutic Area, By End-User, By Region, Forecast & Opportunities, 2026" report...

at 09:28
Biotage AB (publ) Interim report January ? September 2021. July?September Net sales amounted to SEK 305 (263) million, an increase of 16.3 percent and an organic* growth of 17.8 percent.      The operating profit amounted to SEK 68 (61) million. The...

at 09:24
Sierra Donor Services, a division of DCI Donor Services, is utilizing Specialist Direct's Telepathology for Organ Procurement Organizations (OPOs) to increase organ transplant rates in order to save lives. "We're committed to partner with industry...

at 09:20
More than 1,500 members of the global ADHD community will convene from November 4 through 6 for the 2021 Virtual International Conference on ADHD. This premier event, hosted by three leading nonprofit organizations?CHADD (Children and Adults with...

at 09:15
The "Global Healthcare Cloud Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The revenue of the global healthcare cloud computing market is expected to reach $52.30 billion by 2026 up from $11.59 billion in 2020,...

News published on 24 september 2021 at 16:15 and distributed by: